Advertisement

Index by author

June 01, 2007; Volume 71,Issue 6

  1. Davis, Kylie L.

    1. α2A Adrenergic Receptor Activation Inhibits Epileptiform Activity in the Rat Hippocampal CA3 Region
      Chris W. D. Jurgens, Hana M. Hammad, Jessica A. Lichter, Sarah J. Boese, Brian W. Nelson, Brianna L. Goldenstein, Kylie L. Davis, Ke Xu, Kristin L. Hillman, James E. Porter and Van A. Doze
      Molecular Pharmacology June 2007, 71 (6) 1572-1581; DOI: https://doi.org/10.1124/mol.106.031773

  2. Delmas, Patrick

    1. The Amine-Containing Cutaneous Irritant Heptylamine Inhibits the Volume-Regulated Anion Channel and Mobilizes Intracellular Calcium in Normal Human Epidermal Keratinocytes
      Matthieu Raoux, Cécile Colomban, Patrick Delmas and Marcel Crest
      Molecular Pharmacology June 2007, 71 (6) 1685-1694; DOI: https://doi.org/10.1124/mol.106.033324

  3. Denison, Michael S.

    1. Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro
      Wenyue Hu, Claudio Sorrentino, Michael S. Denison, Kyle Kolaja and Mark R. Fielden
      Molecular Pharmacology June 2007, 71 (6) 1475-1486; DOI: https://doi.org/10.1124/mol.106.032748

  4. Deraet, Maud

    1. Modified Receptor Internalization upon Coexpression of 5-HT1B Receptor and 5-HT2B Receptors
      Agnes Janoshazi, Maud Deraet, Jacques Callebert, Vincent Setola, Silke Guenther, Bruno Saubamea, Philippe Manivet, Jean-Marie Launay and Luc Maroteaux
      Molecular Pharmacology June 2007, 71 (6) 1463-1474; DOI: https://doi.org/10.1124/mol.106.032656

  5. Divakaran, Karthika

    1. Identification and Functional Analysis of a Novel Human CYP2E1 Far Upstream Enhancer
      Jeff D. Shadley, Karthika Divakaran, Kimber Munson, Ronald N. Hines, Kirk Douglas and D. Gail McCarver
      Molecular Pharmacology June 2007, 71 (6) 1630-1639; DOI: https://doi.org/10.1124/mol.106.031302

  6. Douglas, Kirk

    1. Identification and Functional Analysis of a Novel Human CYP2E1 Far Upstream Enhancer
      Jeff D. Shadley, Karthika Divakaran, Kimber Munson, Ronald N. Hines, Kirk Douglas and D. Gail McCarver
      Molecular Pharmacology June 2007, 71 (6) 1630-1639; DOI: https://doi.org/10.1124/mol.106.031302

  7. Doze, Van A.

    1. α2A Adrenergic Receptor Activation Inhibits Epileptiform Activity in the Rat Hippocampal CA3 Region
      Chris W. D. Jurgens, Hana M. Hammad, Jessica A. Lichter, Sarah J. Boese, Brian W. Nelson, Brianna L. Goldenstein, Kylie L. Davis, Ke Xu, Kristin L. Hillman, James E. Porter and Van A. Doze
      Molecular Pharmacology June 2007, 71 (6) 1572-1581; DOI: https://doi.org/10.1124/mol.106.031773

  8. Drapeau, Jennifer A.

    1. Pharmacology of α-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant Mice
      Outi Salminen, Jennifer A. Drapeau, J. Michael McIntosh, Allan C. Collins, Michael J. Marks and Sharon R. Grady
      Molecular Pharmacology June 2007, 71 (6) 1563-1571; DOI: https://doi.org/10.1124/mol.106.031492

  9. Drose, Stefan

    1. Mechanism of Thiazolidinedione-Dependent Cell Death in Jurkat T Cells
      Mathias Soller, Stefan Dröse, Ulrich Brandt, Bernhard Brüne and Andreas von Knethen
      Molecular Pharmacology June 2007, 71 (6) 1535-1544; DOI: https://doi.org/10.1124/mol.107.034371

  10. Dubinett, Steven M.

    1. Pioglitazone and Rosiglitazone Decrease Prostaglandin E2 in Non–Small-Cell Lung Cancer Cells by Up-Regulating 15-Hydroxyprostaglandin Dehydrogenase
      Saswati Hazra, Raj K. Batra, Hsin H. Tai, Sherven Sharma, Xiaoyan Cui and Steven M. Dubinett
      Molecular Pharmacology June 2007, 71 (6) 1715-1720; DOI: https://doi.org/10.1124/mol.106.033357
Back to top

In this issue

Advertisement